サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413013

マイナーカンナビノイド市場：製品別、用途別-2024-2030年の世界予測

Minor Cannabinoids Market by Products (Cannabichromene, Cannabigerol, Cannabigerolic Acid), Application (Cancer, Inflammation, Neurological Disorders) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
マイナーカンナビノイド市場：製品別、用途別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

マイナーカンナビノイド市場規模は2023年に176億3,000万米ドルと推計され、2024年には187億9,000万米ドルに達し、CAGR 7.95%で2030年には301億3,000万米ドルに達すると予測されます。

マイナーカンナビノイドの世界市場

主な市場の統計
基準年[2023］ 176億3,000万米ドル
予測年[2024］ 187億9,000万米ドル
予測年 [2030] 301億3,000万米ドル
CAGR（%） 7.95%
マイナーカンナビノイド Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはマイナーカンナビノイド市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、マイナーカンナビノイド市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-マイナーカンナビノイド市場の市場規模および予測は？

2-マイナーカンナビノイド市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-マイナーカンナビノイド市場における技術動向と規制の枠組みは？

4-マイナーカンナビノイド市場における主要ベンダーの市場シェアは？

5-マイナーカンナビノイド市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • マイナーカンナビノイドの医療上の利点
      • カンナビノイドの合法化が進む
      • 新しい微量カンナビノイド飲食品製品のイントロダクション
    • 抑制要因
      • マイナーカンナビノイドのコストが高い
    • 機会
      • マイナーカンナビノイドの継続的な研究開発
      • より良い製品の商品化のための資金と投資
    • 課題
      • マイナーカンナビノイドに関する厳しい規制
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 マイナーカンナビノイド市場：製品別

  • カンナビクロメン
  • カンナビゲロール
  • カンナビゲロール酸
  • カンナビノール
  • テトラヒドロカンナビバリン

第7章 マイナーカンナビノイド市場：用途別

  • がん
  • 炎症
  • 神経学的障害
  • 疼痛管理

第8章 南北アメリカのマイナーカンナビノイド市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のマイナーカンナビノイド市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのマイナーカンナビノイド市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Fresh Bros Hemp Company
    • GenCanna
    • Global Cannabinoids
    • Laurelcrest
    • Mile High labs International
    • Pacific Roots, LLC
    • Rhizo Sciences
    • Sanobiotec
    • Zero Point Extraction, LLC
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. MINOR CANNABINOIDS MARKET RESEARCH PROCESS
  • FIGURE 2. MINOR CANNABINOIDS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. MINOR CANNABINOIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. MINOR CANNABINOIDS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. MINOR CANNABINOIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. MINOR CANNABINOIDS MARKET DYNAMICS
  • FIGURE 7. MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 8. MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. MINOR CANNABINOIDS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. MINOR CANNABINOIDS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. MINOR CANNABINOIDS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. MINOR CANNABINOIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 6. MINOR CANNABINOIDS MARKET SIZE, BY CANNABICHROMENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. MINOR CANNABINOIDS MARKET SIZE, BY CANNABIGEROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. MINOR CANNABINOIDS MARKET SIZE, BY CANNABIGEROLIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. MINOR CANNABINOIDS MARKET SIZE, BY CANNABINOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. MINOR CANNABINOIDS MARKET SIZE, BY TETRAHYDROCANNABIVARIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. MINOR CANNABINOIDS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. MINOR CANNABINOIDS MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. MINOR CANNABINOIDS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. MINOR CANNABINOIDS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. MINOR CANNABINOIDS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 103. MINOR CANNABINOIDS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. MINOR CANNABINOIDS MARKET LICENSE & PRICING
目次
Product Code: MRR-3A2E844FF0B1

[193 Pages Report] The Minor Cannabinoids Market size was estimated at USD 17.63 billion in 2023 and expected to reach USD 18.79 billion in 2024, at a CAGR 7.95% to reach USD 30.13 billion by 2030.

Global Minor Cannabinoids Market

KEY MARKET STATISTICS
Base Year [2023] USD 17.63 billion
Estimated Year [2024] USD 18.79 billion
Forecast Year [2030] USD 30.13 billion
CAGR (%) 7.95%
Minor Cannabinoids Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Minor Cannabinoids Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Minor Cannabinoids Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Minor Cannabinoids Market, highlighting leading vendors and their innovative profiles. These include Fresh Bros Hemp Company, GenCanna, Global Cannabinoids, Laurelcrest, Mile High labs International, Pacific Roots, LLC, Rhizo Sciences, Sanobiotec, and Zero Point Extraction, LLC.

Market Segmentation & Coverage

This research report categorizes the Minor Cannabinoids Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Products
    • Cannabichromene
    • Cannabigerol
    • Cannabigerolic Acid
    • Cannabinol
    • Tetrahydrocannabivarin
  • Application
    • Cancer
    • Inflammation
    • Neurological Disorders
    • Pain Management
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Minor Cannabinoids Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Minor Cannabinoids Market?

3. What are the technology trends and regulatory frameworks in the Minor Cannabinoids Market?

4. What is the market share of the leading vendors in the Minor Cannabinoids Market?

5. Which modes and strategic moves are suitable for entering the Minor Cannabinoids Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Minor Cannabinoids Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Medical benefits of minor cannabinoids
      • 5.1.1.2. Increasing legalization of cannabinoids
      • 5.1.1.3. Introduction of new minor-cannabinoid food & beverage products
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of minor cannabinoids
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D of minor cannabinoids
      • 5.1.3.2. Funding and investments for better product commercialization
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulations regarding minor cannabinoids
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Minor Cannabinoids Market, by Products

  • 6.1. Introduction
  • 6.2. Cannabichromene
  • 6.3. Cannabigerol
  • 6.4. Cannabigerolic Acid
  • 6.5. Cannabinol
  • 6.6. Tetrahydrocannabivarin

7. Minor Cannabinoids Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Inflammation
  • 7.4. Neurological Disorders
  • 7.5. Pain Management

8. Americas Minor Cannabinoids Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Minor Cannabinoids Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Minor Cannabinoids Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Fresh Bros Hemp Company
    • 12.1.2. GenCanna
    • 12.1.3. Global Cannabinoids
    • 12.1.4. Laurelcrest
    • 12.1.5. Mile High labs International
    • 12.1.6. Pacific Roots, LLC
    • 12.1.7. Rhizo Sciences
    • 12.1.8. Sanobiotec
    • 12.1.9. Zero Point Extraction, LLC
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing